DXCM vs XRAY · P/E 63, rev $2.50B vs rev $1.78B
DexCom Inc (DXCM) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the DXCM and XRAY stock pages for the full models.
Not investment advice.